Biggest News Aggregation in the World
๐Ÿ“ฐ Bioscience Inc News

Page 49 - Bioscience Inc News Today

Fast, Ad-Free News Updates

Stay updated with breaking news from Bioscience Inc. Real-time updates on events, politics, business and more.

Yield10 Bioscience (NASDAQ:YTEN) Coverage Initiated by Analysts at Lake Street Capital

Stock analysts at Lake Street Capital began coverage on shares of Yield10 Bioscience (NASDAQ:YTEN – Get Rating) in a report released on Thursday, The Fly reports. The firm set a “buy” rating and a $12.00 price target on the specialty chemicals company’s stock. Lake Street Capital’s price objective indicates a potential upside of 212.50% from […]
United States Thomson Reuter Maxim Group Geode Capital Management Securities Exchange Commission Bioscience Inc

INVO Bioscience (NASDAQ:INVO) Upgraded to "Buy" by Zacks Investment Research

Zacks Investment Research upgraded shares of INVO Bioscience (NASDAQ:INVO – Get Rating) from a hold rating to a buy rating in a report issued on Friday morning, Zacks.com reports. They currently have $2.25 price objective on the stock. According to Zacks, “INVO Bioscience is a medical device company, headquartered in Beverly, Massachusetts, focused on creating […]
United States Claude Ranoux Bioscience Inc Zacks Investment Research Susquehanna International Group Connors Investor Services Inc

PURE Bioscience, Inc. (OTCMKTS:PURE) Short Interest Update

PURE Bioscience, Inc. (OTCMKTS:PURE – Get Rating) saw a large increase in short interest in the month of March. As of March 31st, there was short interest totalling 37,800 shares, an increase of 1,045.5% from the March 15th total of 3,300 shares. Based on an average trading volume of 137,800 shares, the short-interest ratio is […]
United States Pure Bioscience Inc Bioscience Inc Get Rating Pure Bioscience Otcmkts Pure

Stay Updated with Latest News

Get breaking news updates delivered to your inbox

Browse All News โ†’

Yield10 Bioscience (NASDAQ:YTEN) Upgraded at Zacks Investment Research

Yield10 Bioscience (NASDAQ:YTEN – Get Rating) was upgraded by Zacks Investment Research from a “sell” rating to a “hold” rating in a research report issued to clients and investors on Tuesday, Zacks.com reports. According to Zacks, “Yield10 Bioscience, Inc. is an agricultural bioscience company. It focuses on the development of disruptive technologies for improvement in […]
United States Geode Capital Management Securities Exchange Commission Bioscience Inc Zacks Investment Research Maxim Group

Explore More Categories

World News India News Business Technology Sports Entertainment Health Science